New heart drugs struggle to win sales as doctors hold back

LONDON (Reuters) - New heart drugs hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as Novartis, which reported more weak sales for its Entresto medicine on Thursday.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro